CLINICAL_TRIALS
trial_result
· 2021-01-29
Clinical Trial Update: Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion [Phase 2]
Summary
Phase 2a study of allogeneic osteoblastic cells implantation for lumbar spinal fusion completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bone Therapeutics S.A | Conditions: Degenerative Disc Disease | Phase 2 | Status: COMPLETED